Overview

Effect on Orencia (Abatacept) on the Apoptosis of T Cells, B Cells and APC Cells in Rheumatoid Arthritis

Status:
Withdrawn

Trial end date:
2014-11-01

Target enrollment:

Participant gender:

Summary

This proposal will test the hypothesis that Orencia affects apoptosis and apoptosis related genes/biomarkers in vivo in rheumatoid arthritis (RA) patients.

Phase:

Phase 4

Details

Lead Sponsor:

University of California, Los Angeles

Collaborator:

Bristol-Myers Squibb

Treatments:

Abatacept